为药剂师的行为技能开发一个标记系统
Samantha Eve Smith1,2, Joanne Kerins1,3, Scott McColgan-Smith4
1Scottish Centre for Simulation and Clinical Human Factors, Larbert, UK.
The International journal of pharmacy practice
|July 15, 2023
概括
开发了一种新的行为标记系统,以评估药剂师在患者护理模拟中的关键非技术技能. 该工具展示了良好的内容有效性,帮助教育工作者提供有针对性的反,以改善药房实践.
科学领域:
- 药房教育和实践 药房教育和实践
- 医疗保健模拟系统
- 行为科学 行为科学
背景情况:
- 药剂师需要先进的行为技能,以适应不断变化的医疗保健角色.
- 行为标记系统对于在模拟中评估非技术技能至关重要.
- 现有的系统可能无法完全捕捉药剂师以患者为中心的互动的细微差别.
研究的目的:
- 为药剂师开发一种新的行为标记系统,专门用于以患者为中心的护理模拟.
- 评估新开发的药剂师行为标记系统的内容有效性.
- 加强在药房模拟培训中对非技术技能的评估.
主要方法:
- 专家小组审查了关于标记系统和药剂师技能的文献.
- 分析了以患者为中心的场景中药剂师的视频模拟.
- 一个新的行为标记系统通过专家共识反复开发.
- 内容有效性由第三个专家小组使用项目和尺度内容有效性指数进行评估.
主要成果:
- 开发的工具包括四个类别:情境意识,决策/优先级,协作工作和自我意识.
- 每个类别包括3-4个与药房实践相关的特定技能元素.
- 整体规模-内容有效性指数为0.95,表明内容有效性强.
- "领导力或追随力"项目具有0.7的内容有效性指数,低于可接受的切断值.
结论:
- 这是第一个旨在评估药剂师在以患者为中心的模拟中技能的行为标记系统.
- 该系统表现出良好的内容有效性,支持其在药房教育中的实用性.
- 预计将进行进一步的验证,以便为模拟参与者提供个性化的反.
- 该工具旨在改善药剂师基本行为技能的评估和发展.
相关概念视频
Pharmacovigilance
901
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
901
Modeling in Therapy
124
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
124
Drug Abuse and Addiction: Pharmacological Phenomena
544
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
544
Drug Concentrations: Measurements
406
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
406
Drug Administration and Therapy Phases: Overview
555
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
555
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96


